CHRS: Coherus BioSciences, Inc. Stock

by  •  • Comments Off on CHRS: Coherus BioSciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 105.50
Enterprise Value ($M) 245.59
Book Value ($M) -131.99
Book Value / Share -1.14
Price / Book -0.80
NCAV ($M) -218.33
NCAV / Share -1.88
Price / NCAV -0.48

Profitability (mra)
Return on Invested Capital (ROIC) 0.20
Return on Assets (ROA) 0.04
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.41
Current Ratio 2.06

Balance Sheet (mrq) ($M)
Current Assets 362.19
Assets 448.53
Liabilities 580.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 266.96
Operating Income -105.00
Net Income 28.51
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -20.44
Cash from Investing 230.32
Cash from Financing -186.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Rubric Capital Management LP 4.56 -49.44
02-05 13G/A BlackRock, Inc. 9.60 -8.27
07-23 13G/A Temasek Holdings (Private) Ltd 4.80 -10.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 565,448 2,225,684 25.41
2025-04-02 440,080 1,244,034 35.38
2025-04-01 761,797 1,429,967 53.27
2025-03-31 464,705 1,288,248 36.07

(click for more detail)

Similar Companies
BTMD – biote Corp. CADL – Candel Therapeutics, Inc.
CARM – Carisma Therapeutics, Inc. CLSD – Clearside Biomedical, Inc.
CLYM – Climb Bio, Inc.


Financial data and stock pages provided by
Fintel.io